Long-term benefits of omalizumab in a patient with severe non-allergic asthma

INTRODUCTION: Currently, omalizumab is indicated for the treatment of patients with severe allergic uncontrolled asthma despite optimal therapy. CASE PRESENTATION: We studied a 52-year-old man who has been suffering from severe non allergic steroid-resistant asthma with increased levels of total IgE...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Menzella, Francesco, Piro, Roberto, Facciolongo, Nicola, Castagnetti, Claudia, Simonazzi, Anna, Zucchi, Luigi
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2011
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126749/
https://ncbi.nlm.nih.gov/pubmed/21609447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-7-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker